Shift Bioscience has appointed Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, Ph.D., as Non-Executive ...
Shift Bioscience, a Cambridge biotech using an AI powered virtual cell to fight age-related diseases, has made two shrewd hires as it advances its technology. The company has appointed Jill Reckless ...
News-Medical.Net on MSN5d
Circular RNA plays key role in cancer biology and therapyA new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.
AZoLifeSciences on MSN2d
Circular RNA's Transformative Role in Tumor Biology and TreatmentA new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both ...
AZoLifeSciences on MSN1d
The Role of Synthetic Morphogenesis in Advancing Developmental BiologyAdvancements in synthetic morphogenesis are reshaping developmental biology, facilitating the creation of synthetic tissues ...
The global regenerative dentistry market is set for substantial expansion, driven by advancements in cell and molecular ...
A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor ...
Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the ...
A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor ...
Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer cells to reshape treatment for cancer and autoimmune disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback